Biosynthesis of 5α-Cholestan-3β-ol in Cerebrotendinous Xanthomatosis

Gerald Salen; Alan Polito

doi:10.1172/JCI106783

Biosynthesis of 5α-Cholestan-3β-ol in Cerebrotendinous Xanthomatosis

Gerald Salen and Alan Polito

Published January 1, 1972 - More info

View PDF

Abstract

Cerebrotendinous Xanthomatosis is a rare, inherited disease characterized by an extraordinary accumulation of cholestanol in all tissues, xanthomatous deposits in the brain, lungs, and Achilles tendons, premature atherosclerosis, and low plasma cholesterol concentrations. In two patients with the disease, the biosynthesis of cholestanol was examined by different techniques. After cholesterol-4-¹⁴C was injected intravenously into one patient, cholestanol and cholesterol isolated from the bile on 3 different days over the ensuing week contained significant radioactivity. The specific radioactivity-time curves for cholesterol-¹⁴C and cholestanol-¹⁴C suggested a precursor product relationship and provided additional evidence for the transformation of cholesterol into cholestanol. The second patient received intravenously a mixture of mevalonate-2-¹⁴C and stereospecifically labeled mevalonate-3R,4R-³H. Again cholesterol and cholestanol were isolated from the bile, and the ³H/¹⁴C ratio in both sterols was almost the same. This experiment again demonstrated that the biosynthetic path of cholestanol proceeded through cholesterol and not directly from earlier 5α-H-saturated precursors. These two independent lines of evidence indicate that the extraordinary deposition of cholestanol in Cerebrotendinous Xanthomatosis arises from cholesterol presumably through the accentuation of the normal biosynthetic pathway.